Recombinant Human FLJ10803 Protein

Recombinant human FLJ10803 protein is a genetically engineered form of the FLJ10803 protein, encoded by the FLJ10803 gene (also known as C1orf123 or TMEM206), which remains poorly characterized in current scientific literature. Initially identified through genomic sequencing and bioinformatics analyses, FLJ10803 is classified as a hypothetical or uncharacterized protein due to limited functional studies. It is predicted to be a transmembrane protein, with structural domains suggesting potential involvement in ion transport, cell signaling, or membrane trafficking. However, its precise physiological role, interacting partners, and regulatory mechanisms remain speculative. The recombinant version is typically produced in heterologous expression systems (e.g., E. coli, HEK293. or insect cells) to enable biochemical and functional studies. Researchers utilize this protein to investigate its structure-activity relationships, subcellular localization, and possible associations with diseases, including cancers or neurological disorders. Despite its obscurity, interest in FLJ10803 stems from conserved homologs across species and transcriptomic data linking its expression to specific tissues (e.g., brain, liver) or pathological conditions. Current efforts focus on elucidating its role in cellular homeostasis and validating computational predictions experimentally. Its recombinant production facilitates antibody development and high-throughput screening for potential therapeutic applications.